Adolphe, A B · The American journal of medicine · 1988 · DOI
This 1988 study explored whether nifedipine, a blood pressure medication, might help people with chronic fatigue syndrome (ME/CFS). The researchers compared a small group of patients who received the treatment with a control group to see if it made a difference in their symptoms. While the study suggested nifedipine could be worth investigating further, it was very preliminary and limited in scope.
This represents early exploratory work into pharmacological treatments for ME/CFS at a time when treatment options were severely limited. Even preliminary findings can guide future research directions and help clinicians understand potential therapeutic mechanisms worth investigating more rigorously.
This study does not establish that nifedipine is an effective ME/CFS treatment. The case-control design without randomization or placebo control cannot rule out placebo effect, selection bias, or natural disease fluctuation. Results from small, early studies cannot be generalized to broader ME/CFS populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →